Japan Approves Leqembi, All Eyes Now On Extended Pricing Discussions

Concizumab, Tenapanor, Others Get Nods

 
• By Lisa Takagi
  
Japan is going to discuss leqembi's pricing with wide range of effects including cutting down nursing costs.
Japan to discuss Leqembi's pricing from a broad perspective including its potential reduction of care costs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia